TickerTalks
Browse all tickers →
TickerTalks›$ALHC
ALALHC

Alignment Healthcare, Inc.

$ALHC·$3.1B·Medical - Healthcare Plans·Healthcare
$14.85-20.2%YTD-24.8%1Y+7.8%
Mentions · last 7 days
2026-07-25: 15 posts2026-07-26: 7 posts2026-07-27: 8 posts2026-07-28: 8 posts2026-07-29: 18 posts2026-07-30: 36 posts2026-07-31: 42 posts134
Price updated 3h ago·X counts updated 3h ago
ALALHC
$ALHCAlignment Healthcare, Inc.
$14.85-20.20%134 posts
AI analysisFundamentalsVoices on X
Loading…

What it does

Plain-English summary of the business — what they sell and how they make money.

Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Healthcare Plans sits in its cycle right now — and what that implies for $ALHC.

Medical - Healthcare Plans · Healthcare

No material change from last week — Oscar Health's AI-driven clinical platform is gaining member growth while the UNH Medicaid fraud litigation adds regulatory risk to legacy insurers.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+18.2%YTD
+35.4%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
78.4How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
9.2%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
1.2%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
6.7%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.7Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
20.0%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
5.4%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 30, 2026$0.17$0.13+31.8%
Q1 2026Apr 30, 2026$0.05$0.01+400.0%
Q4 2025Feb 26, 2026$-0.05$-0.15+66.7%
Q3 2025Oct 30, 2025$0.02$-0.01+300.0%
Next earningsThu, Oct 29·consensus EPS $0.06

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$1.3B+31.6%-10.8%3.2%$0.17$-9.9M
Q1 FY26$1.2B+33.3%11.7%1.3%$0.06$121.3M
Q4 FY25$1.0B+44.4%12.2%-1.0%$-0.05$-66.6M
Q3 FY25$993.7M+43.5%12.6%0.8%$0.02$160.8M

Forward consensus

5-year forecast · up to 9 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$5.2B$5.2B – $5.2B$0.19$0.13 – $0.239
FY27$6.5B$6.3B – $6.8B$0.43$0.36 – $0.539
FY28$8.1B$7.6B – $8.8B$0.75$0.58 – $0.855
FY29$10.8B$10.5B – $11.3B$1.23$1.19 – $1.302
FY30$13.7B$13.4B – $14.3B$1.66$1.61 – $1.752

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Continues Following Whistleblower Lawsuit Of Financial Manipulationglobenewswire.com·9h agoALHC INVESTORS WITH LOSSES: Contact Block & Leviton About Alignment Healthcare Securities Fraud Investigationnewsfilecorp.com·14h agoKaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of Potential Securities Law Violationsglobenewswire.com·14h agoAlignment Healthcare, Inc. (ALHC) Q2 2026 Earnings Call Transcriptseekingalpha.com·1d agoCompared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metricszacks.com·1d ago

More in Medical - Healthcare Plans

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$UNH$OSCR$CNC$HUM$CVS$CLOV$CI$MOH
Voices on X · top 1 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport